Canon Medical’s Deep Learning Spectral CT Receives FDA Clearance

April 19, 2021—Canon Medical Systems USA, Inc. announced that it has received FDA 510(k) clearance for expanded capabilities into cardiovascular applications.

Available on the company’s Aquilion One/Prism Edition CT system, the Deep Learning Spectral CT allows for acquisition of whole-heart spectral images in one beat because of the system’s 16-cm–wide area detector, 0.275-second whole-heart acquisition with rapid kVp switching, and deep learning spectral reconstruction.

According to the company, the Aquilion One/Prism Edition is designed for deep intelligence. The system integrates artificial intelligence technology to maximize conventional and spectral CT capabilities while providing deep clinical insights to assist physicians in making more informed decisions across the patient’s care cycle.